These developments represent key milestones in Filament's ta...
These developments represent key milestones in Filament's targeted market expansion and financial strategy, as well as significant advancements in their psychedelic drug development platform - highlighting the company's therapeutic and commercial potential.
Press Release: FILAMENT HEALTH ANNOUNCES THIRD QUARTER 2023 FINANCIAL RESULTS AND OPERATIONAL HIGHLIGHTS
Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates.
Read more
Comment
Sign in to post a comment